Google on Tuesday unveiled a new “Create My Widget” feature for Android that allows users to vibe-code their own custom widgets. The feature will first launch on the latest Samsung Galaxy and Google ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

This extension for StarUML(http://staruml.io) support to generate Java code from UML model and to reverse Java code to UML model. Install this extension from ...

Anyone can code using AI. But it might come with a hidden cost. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. Over the past year, AI systems have ...

The Java ecosystem has historically been blessed with great IDEs to work with, including NetBeans, Eclipse and IntelliJ from JetBrains. However, in recent years Microsoft's Visual Studio Code editor ...

Fortnite will finally allow creators to make their own officially-licensed Star Wars minigames, beginning this week. The ability to create Star Wars-themed games within Fortnite has long been promised ...

Fans were gripping fences all Sunday morning as the sounds of racecars serenaded the tens of thousands who flocked to IndyCar’s inaugural Java House Grand Prix of Arlington. Kyle Kirkwood won the race ...

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...